Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lister-James

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biopharmaceutics & Drug Disposition|October 29, 2009
Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphateWei Yin, Elena V Karyagina, Ante S Lundberg, et al.
Nuclear Medicine and Biology|March 1, 2016
Alan Davison, FRSMichael J Abrams, James Kronauge, John Lister-James, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analogMartin J Edelman, Gerry Clamon, Daniel Kahn, et al.
Archives of Internal Medicine|February 18, 2003
Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosisShannon M Bates, John Lister-James, Jim A Julian, et al.
American Journal of Therapeutics|February 1, 1995
Localization of (99m)Tc-Labeled ApoB Synthetic Peptide in Arterial Lesions of an Experimental Model of Spontaneous AtherosclerosisRuth Hardoff, Pat Zanzonico, Frank Braegelmann, et al.
Nuclear Medicine and Biology|November 14, 2007
Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8Sabine Krause, Huub J Rennen, Otto C Boerman, et al.
Journal of Medicinal Chemistry|February 24, 2007
Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studiesJohn E Cyr, Daniel A Pearson, David M Wilson, et al.
Seminars in Nuclear Medicine|June 1, 2011
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agentJohn Lister-James, Michael J Pontecorvo, Chris Clark, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biopharmaceutics & Drug Disposition|October 29, 2009
Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphateWei Yin, Elena V Karyagina, Ante S Lundberg, et al.
Nuclear Medicine and Biology|March 1, 2016
Alan Davison, FRSMichael J Abrams, James Kronauge, John Lister-James, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analogMartin J Edelman, Gerry Clamon, Daniel Kahn, et al.
Archives of Internal Medicine|February 18, 2003
Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosisShannon M Bates, John Lister-James, Jim A Julian, et al.
American Journal of Therapeutics|February 1, 1995
Localization of (99m)Tc-Labeled ApoB Synthetic Peptide in Arterial Lesions of an Experimental Model of Spontaneous AtherosclerosisRuth Hardoff, Pat Zanzonico, Frank Braegelmann, et al.
Nuclear Medicine and Biology|November 14, 2007
Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8Sabine Krause, Huub J Rennen, Otto C Boerman, et al.
Journal of Medicinal Chemistry|February 24, 2007
Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studiesJohn E Cyr, Daniel A Pearson, David M Wilson, et al.
Seminars in Nuclear Medicine|June 1, 2011
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agentJohn Lister-James, Michael J Pontecorvo, Chris Clark, et al.
Pageof 1